GPER1 and melanoma: The data shows that quercetin and luteolin increased P-ERK and c-Myc and these effects were reversed by the specific antagonist of GPER, indicating that the flavonoids’ effects were mediated by GPER, highlighting the potential anti-melanoma therapeutic effects of the two compounds.